Schätzl HM - Search Results

1

A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus.

Schulze K, Staib C, Schätzl HM, Ebensen T, Erfle V, Guzman CA. Schulze K, et al. Among authors: schatzl hm. Vaccine. 2008 Dec 2;26(51):6678-84. doi: 10.1016/j.vaccine.2008.09.006. Vaccine. 2008. PMID: 18805454 Free PMC article.

2

Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS coronavirus infection.

Diemer C, Schneider M, Seebach J, Quaas J, Frösner G, Schätzl HM, Gilch S. Diemer C, et al. Among authors: schatzl hm. J Mol Biol. 2008 Feb 8;376(1):23-34. doi: 10.1016/j.jmb.2007.11.081. Epub 2007 Dec 4. J Mol Biol. 2008. PMID: 18155731 Free PMC article.

3

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

Cosma A, Nagaraj R, Staib C, Diemer C, Wopfner F, Schätzl H, Busch DH, Sutter G, Goebel FD, Erfle V. Cosma A, et al. AIDS Res Hum Retroviruses. 2007 Jun;23(6):782-93. doi: 10.1089/aid.2006.0226. AIDS Res Hum Retroviruses. 2007. PMID: 17604541 Clinical Trial.

4

Therapeutic vaccination reduces HIV sequence variability.

Hoffmann D, Seebach J, Cosma A, Goebel FD, Strimmer K, Schätzl HM, Erfle V. Hoffmann D, et al. Among authors: schatzl hm. FASEB J. 2008 Feb;22(2):437-44. doi: 10.1096/fj.06-7975com. Epub 2007 Oct 10. FASEB J. 2008. PMID: 17932027

5

Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.

Schneider M, Ackermann K, Stuart M, Wex C, Protzer U, Schätzl HM, Gilch S. Schneider M, et al. Among authors: schatzl hm. J Virol. 2012 Sep;86(18):10112-22. doi: 10.1128/JVI.01001-12. Epub 2012 Jul 11. J Virol. 2012. PMID: 22787216 Free PMC article.

6

Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein.

Wopfner F, Weidenhöfer G, Schneider R, von Brunn A, Gilch S, Schwarz TF, Werner T, Schätzl HM. Wopfner F, et al. Among authors: schatzl hm. J Mol Biol. 1999 Jun 25;289(5):1163-78. doi: 10.1006/jmbi.1999.2831. J Mol Biol. 1999. PMID: 10373359

7

The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding.

Heiseke A, Schöbel S, Lichtenthaler SF, Vorberg I, Groschup MH, Kretzschmar H, Schätzl HM, Nunziante M. Heiseke A, et al. Among authors: schatzl hm. Traffic. 2008 Jul;9(7):1116-29. doi: 10.1111/j.1600-0854.2008.00750.x. Epub 2008 Apr 18. Traffic. 2008. PMID: 18419754 Free article.

8

Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses.

Kaiser-Schulz G, Heit A, Quintanilla-Martinez L, Hammerschmidt F, Hess S, Jennen L, Rezaei H, Wagner H, Schätzl HM. Kaiser-Schulz G, et al. Among authors: schatzl hm. J Immunol. 2007 Sep 1;179(5):2797-807. doi: 10.4049/jimmunol.179.5.2797. J Immunol. 2007. PMID: 17709493 Free article.

9

Promising developments bringing prion diseases closer to therapy and prophylaxis.

Gilch S, Schätzl HM. Gilch S, et al. Among authors: schatzl hm. Trends Mol Med. 2003 Sep;9(9):367-9. doi: 10.1016/s1471-4914(03)00144-8. Trends Mol Med. 2003. PMID: 13129701 Review.

10

Prion-like propagation of cytosolic protein aggregates: insights from cell culture models.

Krammer C, Schätzl HM, Vorberg I. Krammer C, et al. Among authors: schatzl hm. Prion. 2009 Oct-Dec;3(4):206-12. doi: 10.4161/pri.3.4.10013. Epub 2009 Oct 4. Prion. 2009. PMID: 19901539 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results